期刊
LIVER INTERNATIONAL
卷 27, 期 9, 页码 1265-1272出版社
BLACKWELL PUBLISHING
DOI: 10.1111/j.1478-3231.2007.01582.x
关键词
Akt; hepatic fibrosis; leptin; phosphatidylinositol 3-kinase (PI3K)
Background/Aims: Leptin has been recognized as a profibrogenic hormone in the liver and is involved in collagen type I formation by activated hepatic stellate cells (HSCs) in response to fibrogenic substances, but the molecular signal mechanisms by which leptin promotes liver fibrogenesis through upregulation of collagen type I expression is not clear. We investigated whether leptin-induced collagen type I is mediated by the Janus kinase-phosphatidylinositol 3-kinase-Akt (JAKs-PI3K-Akt) pathway in a human HSC cell line, LX-2. Methods: LX-2 cells were treated with or without various inhibitors in the presence of leptin. Results: Leptin increased alpha 1(I) collagen mRNA and protein. JAK1, PI3K and Akt were activated after leptin stimulation. AG490, a JAK inhibitor, blocked JAK1 phosphorylation accompanied by inhibition of PI3K and Akt activation as well as alpha 1(I) collagen mRNA expression, indicating a JAK1-dependent mechanism. Wortmannin, a PI3K inhibitor, prevented PI3K and Akt activation and resulted in suppression of alpha 1(I) collagen mRNA expression, suggesting a PI3K-mediated process. These changes were reproduced by overexpression of the dominant-negative p85 alpha mutant. A443654.3, an Akt inhibitor, opposed Akt activation, leading to downregulation of alpha 1(I) collagen mRNA. Overexpression of the dominant-negative Akt mutant led to similar alterations. Conclusion: Leptin has a direct action on liver fibrogenesis by stimulating alpha 1(I) collagen production in activated HSC. The process appears to be mediated by the PI3K/Akt pathway through activated JAK1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据